Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Alfageme

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Archivos De Bronconeumologia|February 21, 2012
Evaluating respiratory patient disabilityJuan Ruiz Manzano, Inmaculada Alfageme Michavila, Eusebi Chiner Vives, et al.
Chronic Respiratory Disease|August 7, 2010
The effect of airflow limitation on the cause of death in patients with COPDInmaculada Alfageme, Nuria Reyes, Mercedes Merino, et al.
Archivos De Bronconeumologia|August 16, 2017
World Lung DayCarlos A Jiménez-Ruiz, Gustavo Zabert, Rogelio Perez Padilla, et al.
Archivos De Bronconeumologia|March 24, 2009
[Health-care quality standards in chronic obstructive pulmonary disease]Juan José Soler-Cataluña, Myriam Calle, Borja G Cosío, et al.
Archivos De Bronconeumologia|May 13, 2017
Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary DiseaseJuan Antonio Riesco Miranda, Bernardino Alcázar, Inmaculada Alfageme, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposureJosé A Rodríguez Portal, Eulogio Rodríguez Becerra, David Rodríguez Rodríguez, et al.
Chest|November 29, 2012
Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classificationJoan B Soriano, Inmaculada Alfageme, Pere Almagro, et al.
The European Respiratory Journal|December 11, 2012
Multicomponent indices to predict survival in COPD: the COCOMICS studyJose M Marin, Inmaculada Alfageme, Pere Almagro, et al.
Plos One|March 4, 2014
Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS studyPere Almagro, Pablo Martinez-Camblor, Joan B Soriano, et al.
Archivos De Bronconeumologia|September 20, 2020
Prevalence and Determinants of COPD in Spain: EPISCAN IIJoan B Soriano, Inmaculada Alfageme, Marc Miravitlles, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Archivos De Bronconeumologia|February 21, 2012
Evaluating respiratory patient disabilityJuan Ruiz Manzano, Inmaculada Alfageme Michavila, Eusebi Chiner Vives, et al.
Chronic Respiratory Disease|August 7, 2010
The effect of airflow limitation on the cause of death in patients with COPDInmaculada Alfageme, Nuria Reyes, Mercedes Merino, et al.
Archivos De Bronconeumologia|August 16, 2017
World Lung DayCarlos A Jiménez-Ruiz, Gustavo Zabert, Rogelio Perez Padilla, et al.
Archivos De Bronconeumologia|March 24, 2009
[Health-care quality standards in chronic obstructive pulmonary disease]Juan José Soler-Cataluña, Myriam Calle, Borja G Cosío, et al.
Archivos De Bronconeumologia|May 13, 2017
Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary DiseaseJuan Antonio Riesco Miranda, Bernardino Alcázar, Inmaculada Alfageme, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposureJosé A Rodríguez Portal, Eulogio Rodríguez Becerra, David Rodríguez Rodríguez, et al.
Chest|November 29, 2012
Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classificationJoan B Soriano, Inmaculada Alfageme, Pere Almagro, et al.
The European Respiratory Journal|December 11, 2012
Multicomponent indices to predict survival in COPD: the COCOMICS studyJose M Marin, Inmaculada Alfageme, Pere Almagro, et al.
Plos One|March 4, 2014
Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS studyPere Almagro, Pablo Martinez-Camblor, Joan B Soriano, et al.
Archivos De Bronconeumologia|September 20, 2020
Prevalence and Determinants of COPD in Spain: EPISCAN IIJoan B Soriano, Inmaculada Alfageme, Marc Miravitlles, et al.
Pageof 6